Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 346-353

  Charrier, J ^a,b   Maugard, C M ^a,b   Le Mevel, B ^a   Bignon, Y J ^b  

^a CENTRE RENÉ GAUDUCHEAU   (France)

^b CENTRE JEAN PERRIN   (France)

Author keywords

Allelic polymorphism; Breast cancer; Cancer susceptibility; Glutathione S transferase

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032944428     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690055     Document Type: Article

References (38)

1. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Laughlin R, Nemoto T, Michalek AM, Harrington A, Ford TD and Shields PG (1995) Cytochrome P450 1A1 and glutathione S-transferase (Ml) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55: 3483-3485
2. Claus EB (1994) Genetic epidemiology of breast cancer in younger women. J Natl Cancer Inst Monogr 16: 49-53
3. Comstock KE, Sanderson BJS, Claflin G and Henner WD (1990) GSTI gene deletion determined by polymerase chain reaction. Nucleic Acids Res 18: 3670
4. Doll R and Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66: 1191-1308
5. Duncan H, Swan C, Green J, Jones P, Brannigan K, Alldersea J, Fryer AA and Strange RC (1495) Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTMI and GSTTI genotypes. Clin Chim Acta 240: 53-61
6. Easton D, Ford D and Peto J (1993) Inherited susceptibility to breast cancer. Cancer Surv 18: 95-113
7. Easton D (1997) Breast cancer genes - what are the real risks? Nature Genet 16: 210-211
8. Franceschi S, La Vecchia C, Negri E, Parazzini F and Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26: 781-785
9. Fryer AA, Zhao L, Alldersea J, Pearson WR and Strange RC (1993a) Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTMI A, GSTMI B, GSTMI A, B and GSTMI null polymorphisms at the glutathione S-transferase, GSTMI locus. Biochem J 295: 313-315
10. Fryer AA, Zhao L, Alldersea J, Boggild MD, Perrett CW, Clayton RN, Jones PW and Strange RC (1993b) The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTMI 0 genotype in patients with pituitary adenomas. Carcinogenesis 14: 563-566
11. Garcia-Closas M, Kelsey KT, Wieneke JK and Christiani DC (1995) Nutrient intake as a modifier of the association between smoking-induced lung cancer and glutathione S-tranferase μ deletion. Proc Am Ass Cancer Res 36: 281
12. Harada S, Misawa S, Nakamura T, Tanaka N, Ueno E and Nozoe M (1992) Detection of GSTI gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese. Hum Genet 90: 62-64.
13. Heagerty AHM, Fitzgerald D, Smith A, Bowers B, Jones P, Fryer AA, Zhao L, Alldersea J and Strange RC (1994) Glutathione S-transferase GSTMI phenotypes and protection against cutaneous tumours. Lancet 343: 266-268
14. Hunter DJ and Willet WC (1994) Diet, body build, and breast cancer. Annut Rev Nutr 14: 393-418
15. Katoh A, Watzlaf VJM and D'Amico F (1994) An examination of obesity and breast cancer survival in post-menopausal women. Br J Cancer 70: 928-933
16. Kihara M, Kihara M and Noda K (1994) Lung cancer risk of GSTMI null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis 15: 415-418
17. Lin HJ, Han C, Bernstein DA, Hsiao W, Lin BK and Hardy S (1994) Ethnic distribution of the glutathione transferase Mu 1 - 1 (GSTMI) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 15: 1077-1081
18. Miettinen O (1976) Estimability and estimation in case-referent studies. Am J Epidemiol 103: 226-235
19. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tastigian S, Lin Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, Mc Clure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrisson P, Rosteck P, Lai M, Barett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science 266: 66-71
20. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG and Gomella LG (1992) Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 52: 6110-6112
21. Nakachi K, Imai K, Hayashi S and Kawajari K (1993) Polymorphisms of the CypIAI and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53: 2994-2999
22. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng ZT, Stapleton P and Weiss NS (1993) The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53: 2313-2318
23. Ollier W, Davies E, Snowden N, Alldersea J, Fryer A, Jones P and Strange R (1996) Association of homozygosity for glutathione-S-transferase GSTMI null alleles with the RO+/La autoantibody profile in patients with systemic lupus erythematosus. Arthr Rheum 39: 1763-1764
24. Paradiso A, Vetrugno MG, Capuano G, Longo S, Sibilano L, Schittuli F, Correale M, Barletta A, Pelagio G and De Lena (1994) Expression of GST-μ transferase in breast cancer patients and healthy controls. Int J Biol Markers 9: 219-223
25. Pearson WR, Vorachek WR, Xu S, Berger R, Hart I, Vannais D and Patterson D (1993) Identification of class-mu glutathione transferase genes GSTMI GSTM5 on human chromosome Ip13. Am J Hum Genet 53: 220-233
26. Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE and Narod SA (1996) Ovarian cancer risk in BRCAI carriers is modified by the HRASI variable number of tandem repeat (VNTR) locus. Nat Genet 12: 309-311
27. Rebbeck TR, Couch FJ, Kant J, Calzone K, DeShano M, Peng Y, Chen K, Garber JE and Weber BL (1996) Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2. Am J Hum Genet 59: 547-553
28. Sambrook J, Fritsch EF and Maniatis T (1989) Commonly used techniques in molecular cloning. Purification of nucleic acids. Extraction with phenol: chloroform. In Molecular Cloning. A laboratory manual, 2nd edn. pp. E3-E4 Sambrook J, Fritsch EF, Maniatis T (eds) Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY
29. Seidegard J, Pero RW, Miller DG and Beattie EJ (1986) A glutathione transferase in human leucocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 7: 751-753
30. Seidegard J and Pero RW (1988) The genetic variation and the expression of human glutathione transferase mu. Klin Wochenschr 66: 125-126
31. Seidegard J, Vorachek WR, Pero RW and Pearson WR (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85: 7293-7297
32. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG and Beattie EJ (1990) Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis 11: 33-36
33. Smith G, Stanley LA, Sim E, Strange RC and Wolf CR (1995) Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25: 27-65
34. Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB and Deakin M (1991) The human glutathione S-transferases: a case-control study of the incidence of the GSTI 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12: 25-28
35. Szabo CI and King MC (1997) Population genetics of BRCA1 and 2. Am J Hum Genet 60: 1013-1020
36. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsonn J, Ficenee D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A and Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792
37. Yengi L, Inskip J, Gilford J, Alldersea J, Bailey L, Lear JT, Heagerty AH, Bowers P, Hand P, Hayes JD, Jones PW, Strange RC and Fryer AA (1996) Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 56: 1974-1977
38. Zhong S, Wyllie AH, Barnes D, Wolf CR and Spurr NK (1993) Relationship between the GSTMI genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-1824